Intranasal Resveratrol Nanoparticles Enhance Neuroprotection in a Model of Multiple Sclerosis.

On day 28, 1.27 mg/kg RNs, 8.44 mg/kg RNs and 8.44 mg/kg RSV showed a small trend toward higher visual responses compared to the 8.44 mg/kg vehicle, but this was not significant (0.13 ± 0.04, 0.12 ± 0.03 and 0.17 ± 0.06 vs. 0.08 ± 0.03 OKR scores, p > 0.05), as shown in Figure 3 B. 2.3.

also in 150 other papers

2280 ± 330 cells/1.56 mm 2 , p < 0.05) as shown in Figure 1 , and treatment with intranasal 1.27 mg/kg RNs (n = 6 mice) showed a trend toward increased RGC survival (3070 ± 426 cells/1.56 mm 2 ).

also in 13,339 other papers